In a recent LinkedIn post, Sharon Kedar, CFA discusses critical areas where advancements are urgently needed in breast cancer treatment and care, highlighting disparities and outdated practices.
Kedar, CFA points out that despite improvements in survival rates, the progress in addressing the impact of breast cancer on women and their families is not sufficient. She emphasizes that certain aspects of breast cancer surgery have seen little innovation over the past three decades.
“Did we know that breast cancer surgery has not been innovated for 30 years (we can do better)”
This stagnation in surgical innovation, as highlighted by Kedar, CFA, suggests a significant gap between current capabilities and potential improvements in patient outcomes. The post further delves into financial disparities within the healthcare system.
Addressing Healthcare Disparities
A key concern raised by Sharon Kedar, CFA is the unequal reimbursement rates for medical procedures based on gender. She asserts that surgeries for women are reimbursed at a considerably lower rate compared to those for men, indicating a systemic issue that may affect the quality or availability of care.
“Women’s surgeries are reimbursed at 20% less than men’s surgeries”
According to Kedar, CFA, this financial discrepancy is a critical factor that needs to be addressed to ensure equitable healthcare for all. She argues that such disparities can have far-reaching consequences for both patients and healthcare providers.
Improving Diagnostic Tools and Access
Beyond surgical and financial aspects, Kedar, CFA also draws attention to the importance of diagnostic tools. She specifically mentions the lifetime risk assessment for breast cancer, a crucial factor in determining the necessity and benefit of an MRI scan.
“And the lifetime risk for breast cancer, a key assessment to know if a woman would benefit from an MRI, is not as common as it needs to be.”
In Kedar, CFA’s view, the current infrequent application of this risk assessment is a missed opportunity to provide timely and personalized care. She advocates for broader and more consistent use of such assessments to improve early detection and intervention strategies.
A Call for Better Care
Sharon Kedar, CFA concludes her post by emphasizing the personal connection to this cause, mentioning her sister-in-law, Danielle Maged. This personalizes the broader systemic issues she has raised, underscoring the human impact of these challenges.
“Danielle Maged is my sister in law. She, women all over the world, and their families deserve so much better. ❤️”
Through her post, Kedar, CFA makes a compelling case for renewed focus on innovation, equity, and improved diagnostic practices within breast cancer care, calling for collective action to ensure better outcomes for women globally.
📝 About This Content
This article is based on insights shared by Sharon Kedar, CFA on LinkedIn.
📅 Originally posted on August 4, 2026 | View original post on LinkedIn →